|
EP2703496A1
|
|
Combination of PCR primers and a method for detection and identification of Human Papillomavirus (HPV)
|
|
EP2677321A1
|
|
Integrated device for nucleic acid hybridizations and immuno-assays
|
|
EP2508618A1
|
|
Methods and means for determining a functional polymorphism in ficolin-2 for predicting the outcome of kidney transplantation
|
|
US2011059092A1
|
|
Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs
|
|
WO2009040438A2
|
|
Markers for the prognosis of lung function and colonization with an infectious agent
|
|
WO2008107377A2
|
|
Combinations of markers for sepsis risk assessment
|
|
EP2121990A2
|
|
Methodology for anaysis of sequence variations within the hcv ns5b genomic region
|
|
WO2008046923A2
|
|
Methodology for analysis of sequence variations within the hcv ns3/4a genomic region
|
|
EP2463390A1
|
|
Methodology for analysis of sequence variations within the HCV NS5B genomic region
|
|
JP2007289204A
|
|
Construct and method for expression of recombinant hcv envelop protein
|
|
WO2007028795A1
|
|
Nucleic acid variants in the masp-2 gene associated with altered innate immunity
|
|
EP1931801A2
|
|
Nucleic acid variants in the toll like receptor genes associated with altered innate immunity
|
|
WO2007023148A2
|
|
Nucleic acid variants in the lbp gene associated with altered innate immunity
|
|
EP1881081A1
|
|
Combinations of markers for increased accuracy of diagnosis of rheumatoid arthritis
|
|
US2007048281A1
|
|
Hcv combination therapy
|
|
AU2006224789A1
|
|
Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
|
|
WO2006097388A2
|
|
Nucleic acid variants in the c1qr1 gene associated with altered innate immunity.
|
|
CA2594341A1
|
|
Nucleic acid variants in the ficolin genes associated with altered innate immunity
|
|
EP1756147A2
|
|
Peptides for inducing a ctl and/or htl response to hepatitis c virus
|
|
EP1602664A1
|
|
HCV E1 comprising specific disulfide bridges
|
